Integra LifeSciences Holdings Corporation IL3.F Stock
Integra LifeSciences Holdings Corporation Price Chart
Integra LifeSciences Holdings Corporation IL3.F Financial and Trading Overview
Contents
- Integra LifeSciences Holdings Corporation Price Chart
- Integra LifeSciences Holdings Corporation IL3.F Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Integra LifeSciences Holdings Corporation
- Q&A For Integra LifeSciences Holdings Corporation Stock
Integra LifeSciences Holdings Corporation stock price | 30.8 EUR |
Previous Close | 37.6 EUR |
Open | 37.6 EUR |
Bid | 37.6 EUR x N/A |
Ask | 37.8 EUR x N/A |
Day's Range | 37.6 - 37.6 EUR |
52 Week Range | 35.6 - 56.5 EUR |
Volume | 40 EUR |
Avg. Volume | 2 EUR |
Market Cap | 3.08B EUR |
Beta (5Y Monthly) | 1.160915 |
PE Ratio (TTM) | 19.481865 |
EPS (TTM) | 0.78 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 77.7 EUR |
IL3.F Valuation Measures
Enterprise Value | 4.42B EUR |
Trailing P/E | 19.481865 |
Forward P/E | 10.994151 |
PEG Ratio (5 yr expected) | 1.42 |
Price/Sales (ttm) | 1.9717373 |
Price/Book (mrq) | 1.8384509 |
Enterprise Value/Revenue | 2.829 |
Enterprise Value/EBITDA | 11.323 |
Trading Information
Integra LifeSciences Holdings Corporation Stock Price History
Beta (5Y Monthly) | 1.160915 |
52-Week Change | -25.098% |
S&P500 52-Week Change | 20.43% |
52 Week High | 56.5 EUR |
52 Week Low | 35.6 EUR |
50-Day Moving Average | 46.31 EUR |
200-Day Moving Average | 49.18 EUR |
IL3.F Share Statistics
Avg. Volume (3 month) | 2 EUR |
Avg. Daily Volume (10-Days) | 4 EUR |
Shares Outstanding | 81.9M |
Float | 70.81M |
Short Ratio | N/A |
% Held by Insiders | 13.08% |
% Held by Institutions | 94.59% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 11.00% |
Operating Margin (ttm) | 17.32% |
Gross Margin | 62.89% |
EBITDA Margin | 24.98% |
Management Effectiveness
Return on Assets (ttm) | 4.56% |
Return on Equity (ttm) | 10.44% |
Income Statement
Revenue (ttm) | 1.56B EUR |
Revenue Per Share (ttm) | 18.92 EUR |
Quarterly Revenue Growth (yoy) | 1.09% |
Gross Profit (ttm) | 982.03M EUR |
EBITDA | 390.26M EUR |
Net Income Avi to Common (ttm) | 171.88M EUR |
Diluted EPS (ttm) | 1.93 |
Quarterly Earnings Growth (yoy) | -26.40% |
Balance Sheet
Total Cash (mrq) | 323.03M EUR |
Total Cash Per Share (mrq) | 3.94 EUR |
Total Debt (mrq) | 1.61B EUR |
Total Debt/Equity (mrq) | 96.32 EUR |
Current Ratio (mrq) | 3.647 |
Book Value Per Share (mrq) | 20.452 |
Cash Flow Statement
Operating Cash Flow (ttm) | 246.28M EUR |
Levered Free Cash Flow (ttm) | 212.63M EUR |
Profile of Integra LifeSciences Holdings Corporation
Country | Germany |
State | NJ |
City | Princeton |
Address | 1100 Campus Road |
ZIP | 08540 |
Phone | 609 275 0500 |
Website | https://www.integralife.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 3722 |
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Q&A For Integra LifeSciences Holdings Corporation Stock
What is a current IL3.F stock price?
Integra LifeSciences Holdings Corporation IL3.F stock price today per share is 30.8 EUR.
How to purchase Integra LifeSciences Holdings Corporation stock?
You can buy IL3.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Integra LifeSciences Holdings Corporation?
The stock symbol or ticker of Integra LifeSciences Holdings Corporation is IL3.F.
Which industry does the Integra LifeSciences Holdings Corporation company belong to?
The Integra LifeSciences Holdings Corporation industry is Medical Devices.
How many shares does Integra LifeSciences Holdings Corporation have in circulation?
The max supply of Integra LifeSciences Holdings Corporation shares is 78.6M.
What is Integra LifeSciences Holdings Corporation Price to Earnings Ratio (PE Ratio)?
Integra LifeSciences Holdings Corporation PE Ratio is 39.48718000 now.
What was Integra LifeSciences Holdings Corporation earnings per share over the trailing 12 months (TTM)?
Integra LifeSciences Holdings Corporation EPS is 0.78 EUR over the trailing 12 months.
Which sector does the Integra LifeSciences Holdings Corporation company belong to?
The Integra LifeSciences Holdings Corporation sector is Healthcare.